REVIEW 4 major objections 5 minor 18 references
Transfer Learning and Explainable AI for Brain Tumor Classification: A Study Using MRI Data from Bangladesh
T0 review · 4 major / 5 minor · reviewed 2026-08-07 · deepseek-v4-flash
Pith's one-line read The paper claims that fine-tuned VGG16 can classify Bangladeshi brain MRI scans into glioma, meningioma, and tumor classes with 99.17% accuracy, and that Grad-CAM and Grad-CAM++ heatmaps localize the tumor regions driving the predictions.
desk verdict A routine but internally consistent transfer-learning benchmark on a new Bangladeshi MRI dataset; the headline VGG16 accuracy checks out against the confusion matrix, yet unreported splitting and table inconsistencies undercut reproducibility. read the letter →
The pith
A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.
The reading
What carries the argument
The central mechanism is the transfer learning architecture: ImageNet-pretrained convolutional feature extractors (VGG16, VGG19, DenseNet, InceptionResNetV2, MobileNetV2, Xception, ResNet50V2, InceptionV3) topped with flatten, dense, and dropout layers and fine-tuned on resized, normalized, and augmented 128x128 MRI images. Training uses sparse categorical cross-entropy with Adam optimization over roughly 30 epochs. The explainability machinery is Grad-CAM, which weights feature maps by globally averaged gradients to produce a class-discriminative heatmap, and Grad-CAM++, which adds second-order gradient terms for finer localization; these heatmaps are the object that links the high accuracy claim to the clinical-transparency claim.
What would settle it
Re-run the experiment on the same dataset but with a fixed random seed, stratified by class, and with a sample of labels checked by a radiologist; if VGG16's accuracy falls materially below 99.17% or per-class F1 varies widely across seeds, the published figure reflects split luck or label leakage rather than generalization. A second check: test the same fine-tuned VGG16 on MRI scans from a different Bangladeshi hospital not represented in the dataset and see whether accuracy stays near 99%.
Extended reading notes
Core claim
On its own terms, the paper's central claim is empirical: on the Bangladesh Brain Cancer MRI Dataset, fine-tuned VGG16 is the best of the eight transfer learning models tested, with 99.17% disease accuracy and per-class F1 scores at or near 0.98 for glioma, meningioma, and tumor. VGG19 and DenseNet follow at 98% accuracy. The paper further claims that Grad-CAM and Grad-CAM++ visualizations show the models fixating on tumor cores, with Grad-CAM++ giving finer localization in anatomically complex cases such as glioma, and it treats this overlap as evidence that predictions rest on clinically meaningful regions. The proposed contribution is therefore not a new network but a combination of a publicly available local dataset, a fine-tuning recipe, and dual XAI display.
Load-bearing premise
The load-bearing premise is that the 'Brain Cancer - MRI Dataset' is correctly labeled and representative of Bangladeshi clinical MRI practice, and that the 80:10:10 split is a random, unbiased sample; the paper verifies neither the labels nor the split's class balance.
Editorial extensions
If this is right
- If the 99.17% figure holds, fine-tuned VGG16 can be deployed as a high-accuracy first-pass classifier on Bangladeshi hospital MRI scans, with per-class F1 scores around 0.98.
- The Grad-CAM/Grad-CAM++ heatmaps provide an inspectable rationale for each prediction, which is the missing piece for clinicians to trust automated reads in low-resource settings.
- The same fine-tuning recipe, pretrained weights plus custom dense layers plus augmentation, can be transferred to other neuroimaging classification tasks where local data is scarce.
- The comparison table implies that accuracy parity with earlier Bangladeshi studies is achievable without a custom architecture, so the practical differentiator is local validation and explainability rather than model design.
Reading between the lines
- Because the paper reports no random seed, no stratified split, and test-set class counts (209/217/180 in Figure 4(a)) that deviate from the dataset's proportional split, the headline accuracy is likely to shift under repeated random splits; a seeded, stratified replication would give a more honest estimate.
- The dataset's images come from a single public collection, so 99.17% accuracy says little about performance on scans from different machines or protocols; an external validation on a second Bangladeshi hospital's MRI data would test domain transfer.
- If label noise exists (unverified labels are a plausible source), the high agreement between Grad-CAM and Grad-CAM++ mainly shows the model learned the dataset's cues, not that those cues are clinically correct; expert label verification would separate these two readings.
- A practical extension: the same pipeline could be reshaped into a screening tool that flags suspicious scans for radiologist review, with the heatmap as the human-checkable evidence.
Editorial analysis
A structured set of objections, weighed in public.
Referee Report
Summary. The manuscript reports a transfer-learning study for classifying three brain-tumor classes (glioma, meningioma, tumor) in a publicly available MRI dataset sourced from Bangladeshi hospitals. Eight pretrained CNN architectures are fine-tuned, with VGG16 reported as the best at 99.17% accuracy. Grad-CAM and Grad-CAM++ are used to produce heatmaps intended to show which image regions drive the classifications. The paper's central claims are that VGG16 outperforms the other models, that the localized Bangladeshi dataset provides a region-specific contribution, and that the dual-XAI approach improves clinical interpretability.
Significance. If the results hold, the study would provide a useful reference point for applying standard transfer-learning pipelines to a regional MRI dataset, with a plausible accuracy level in line with prior work on the same task. The attempted use of two XAI methods adds transparency, although the evaluation of the explanations is qualitative. The main contribution is the use of a Bangladeshi dataset and the comparative benchmarking, which is incremental but potentially useful for practitioners in low-resource settings. The paper would be strengthened by making the split reproducible and by reconciling the reported per-class metrics with the confusion matrices.
major comments (4)
- [§4, Table 1 vs Figure 4(a)] Table 1 and Figure 4(a) are internally inconsistent for the central models. For VGG16, the confusion matrix gives Glioma precision 207/207 = 1.00 and recall 207/209 = 0.99, yet Table 1 lists 0.98 precision, 0.98 recall, and 0.98 F1. Similar discrepancies appear for other classes and for VGG19 (e.g., Figure 4(b) implies Meningioma recall 207/217 = 0.95, not 0.97 as printed). Because Table 1 is the primary evidence for the comparative claim that VGG16 is best, these inconsistencies undermine the detailed performance comparison and must be corrected or explained.
- [§3.3, Dataset Splitting] The train/validation/test split is not reproducible. Section 3.3 specifies an 80:10:10 ratio but gives no random seed and does not mention stratification. The test counts implied by Figure 4(a) (209 glioma, 217 meningioma, 180 tumor) deviate markedly from what a simple random 10% split would be expected to yield under the dataset proportions of Section 3.1 (roughly 200, 200, and 205): the tumor count of 180 is approximately 2.1 standard deviations below expectation. Without a released split, a seed, or stratification details, the central 99.17% accuracy claim cannot be independently verified, and the possibility that the test set is unrepresentative remains open.
- [§5, Explainable AI evaluation] The claim that Grad-CAM and Grad-CAM++ heatmaps 'validate' the model's predictions is not supported by any quantitative or structured evaluation. Section 5 states that overlapping highlighted regions 'validates their importance,' but no overlap metric, expert reader study, or comparison against tumor segmentations is provided. Since explainability is a stated contribution of the paper, the current qualitative demonstration is insufficient to support the claim that the XAI component enhances 'stability' or clinical trust.
- [§4, Experimental reproducibility] Key hyperparameters and experimental details are under-reported. Section 4 mentions 30 epochs, a learning-rate range from 1e-3 to 1e-5, and the Adam optimizer, but does not report the exact learning rate, batch size, dropout values, or early-stopping criteria for each model. No code or configuration files are provided. These omissions hamper replication, especially given that the split itself is not reproducible.
minor comments (5)
- [Title and keywords] The title contains a typo ('A S TUDY' should be 'A STUDY') and the keyword list includes 'VGGNNet', which appears to be a misspelling of 'VGGNet'.
- [§3.1, Dataset provenance] The claim that the dataset 'was collected from various hospitals across Bangladesh' is taken from the Mendeley record [13]; the manuscript provides no additional verification of the provenance or of label quality. This is worth stating as a limitation.
- [§3.3, Wording] The phrase 'This division guarantees a balanced training methodology' is imprecise: an 80:10:10 split does not by itself guarantee class balance, and the paper does not report using stratified sampling.
- [§4, Table 1 layout] The formatting of Table 1 is ambiguous: the accuracy column appears once but the per-class precision/recall/F1 rows are nested under each model. This layout makes it easy to misread the table and should be reformatted for clarity.
- [§5, Equations] The Grad-CAM++ equation uses the same symbol α_c^k as Grad-CAM but with a different weighting scheme; the notation does not make clear that the two equations define different quantities. A brief sentence distinguishing the two weight definitions would improve readability.
Circularity Check
No significant circularity: the reported accuracy is a held-out test-set result and the Grad-CAM analyses are post-hoc; internal inconsistencies and reproducibility concerns are not circularity.
full rationale
The paper's central quantitative claim—VGG16 achieving 99.17% accuracy—is obtained from a held-out test split of the Mendeley Bangladesh Brain Cancer MRI Dataset, as described in Section 3.3 (80:10:10 split) and Section 4 (Table 1, Figure 4). The accuracy is a measured test-set performance, not a quantity defined in terms of the models' training objectives or fitted parameters, so it is not circular in the model-fitting sense. The Grad-CAM and Grad-CAM++ explanations (Section 5) are applied post-hoc to trained models and do not feed back into training or into the accuracy computation; their formulas are standard external results cited to [16] and [18]. The paper does not fit a parameter to a subset and then predict a closely related quantity, and it does not rely on a self-citation chain to justify its central result. The qualitative statement that overlapping Grad-CAM/Grad-CAM++ regions 'validates' predictions is weak as an external validation argument because it compares two explanations rather than against ground truth, but this is an interpretive limitation, not a derivation that reduces by construction to the paper's inputs. The skeptic's concerns about unreported split seeds, non-stratification, inconsistent test counts, and disagreement between Table 1 and Figure 4(a) are legitimate validity and reproducibility issues, but they belong to correctness risk rather than circularity. Therefore no circular step is established under the required evidentiary standard.
Assumptions & free parameters
free parameters (3)
- Learning rate =
not reported (tuned in 1e-3 to 1e-5)
- Augmentation hyperparameters =
noise std 0.0023, contrast 0.79, brightness 0.24, rotations ±9°, ±13°
- Number of epochs =
30 (average)
assumptions (4)
- domain assumption The 6,056-image Mendeley Bangladesh Brain Cancer MRI Dataset labels (glioma, meningioma, tumor) are correct and the images are clinically representative.
- domain assumption ImageNet-pretrained features transfer meaningfully to brain MRI after fine-tuning.
- domain assumption The 80:10:10 split is a random representative partition.
- standard math Grad-CAM and Grad-CAM++ equations (Section 5) are standard and correctly implemented.
Cite this review
Pith. "Pith review of Transfer Learning and Explainable AI for Brain Tumor Classification: A Study Using MRI Data from Bangladesh." pith.science (2026). https://pith.science/paper/ZKJBTPMZ
@misc{pith2026250607228,
author = {Pith},
title = {Pith review of: Transfer Learning and Explainable AI for Brain Tumor Classification: A Study Using MRI Data from Bangladesh},
year = {2026},
howpublished = {\url{https://pith.science/paper/ZKJBTPMZ}},
note = {Machine review of arXiv:2506.07228}
}
read the original abstract
Brain tumors, regardless of being benign or malignant, pose considerable health risks, with malignant tumors being more perilous due to their swift and uncontrolled proliferation, resulting in malignancy. Timely identification is crucial for enhancing patient outcomes, particularly in nations such as Bangladesh, where healthcare infrastructure is constrained. Manual MRI analysis is arduous and susceptible to inaccuracies, rendering it inefficient for prompt diagnosis. This research sought to tackle these problems by creating an automated brain tumor classification system utilizing MRI data obtained from many hospitals in Bangladesh. Advanced deep learning models, including VGG16, VGG19, and ResNet50, were utilized to classify glioma, meningioma, and various brain cancers. Explainable AI (XAI) methodologies, such as Grad-CAM and Grad-CAM++, were employed to improve model interpretability by emphasizing the critical areas in MRI scans that influenced the categorization. VGG16 achieved the most accuracy, attaining 99.17%. The integration of XAI enhanced the system's transparency and stability, rendering it more appropriate for clinical application in resource-limited environments such as Bangladesh. This study highlights the capability of deep learning models, in conjunction with explainable artificial intelligence (XAI), to enhance brain tumor detection and identification in areas with restricted access to advanced medical technologies.
Figures
Figures from the paper (2 more)
Reference graph
Works this paper leans on
-
[1]
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
Roger Stupp, Warren P Mason, Martin J Van Den Bent, Michael Weller, Barbara Fisher, Martin JB Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England journal of medicine, 352(10):987–996, 2005
work page 2005
-
[2]
Brain tumor detection using convolutional neural network
Tonmoy Hossain, Fairuz Shadmani Shishir, Mohsena Ashraf, MD Abdullah Al Nasim, and Faisal Muhammad Shah. Brain tumor detection using convolutional neural network. In2019 1st international conference on advances in science, engineering and robotics technology (ICASERT), pages 1–6. IEEE, 2019
work page 2019
-
[3]
Md Tanvir Rouf Shawon, GM Shibli, Farzad Ahmed, and Sajib Kumar Saha Joy. Explainable cost-sensitive deep neural networks for brain tumor detection from brain mri images considering data imbalance. arXiv preprint arXiv:2308.00608, 2023
work page Pith review arXiv 2023
-
[4]
Md Naim Islam, Md Shafiul Azam, Md Samiul Islam, Muntasir Hasan Kanchan, AHM Shahariar Parvez, and Md Monirul Islam. An improved deep learning-based hybrid model with ensemble techniques for brain tumor detection from mri image. Informatics in Medicine Unlocked, 47:101483, 2024
work page 2024
-
[5]
Md Monirul Islam, Prema Barua, Moshiur Rahman, Tanvir Ahammed, Laboni Akter, and Jia Uddin. Transfer learning architectures with fine-tuning for brain tumor classification using magnetic resonance imaging.Healthcare Analytics, 4:100270, 2023
work page 2023
-
[6]
Multi-class brain lesion classification using deep transfer learning with mobilenetv3
Ahmed Firas Majeed, Pedram Salehpour, Leili Farzinvash, and Saeid Pashazadeh. Multi-class brain lesion classification using deep transfer learning with mobilenetv3. IEEE Access, 2024
work page 2024
-
[7]
Md Atikur Rahman, Arpita Ghosh, Md Shohanur Rahman, and Md Abu Bakar Siddique. A comparative analysis and visualizable of mri image type-based brain tumor classification using transfer learning models. In 2024 6th International Conference on Electrical Engineering and Information & Communication Technology (ICEEICT), pages 7–12. IEEE, 2024
work page 2024
-
[8]
Detection and classification of brain tumor using support vector machine based gui
Imran Ullah Khan, Shamim Akhter, and Shaheen Khan. Detection and classification of brain tumor using support vector machine based gui. In 2020 7th International conference on signal processing and integrated networks (SPIN), pages 739–744. IEEE, 2020
work page 2020
Show all 18 references
-
[9]
Hybrid model-based brain tumor detection and classification using deep cnn-svm
Shaila Shanjida, Md Saiful Islam, and Mohammad Mohiuddin. Hybrid model-based brain tumor detection and classification using deep cnn-svm. In 2024 6th International Conference on Electrical Engineering and Information & Communication Technology (ICEEICT), pages 1467–1472. IEEE, 2024
2024
-
[10]
Brainnet: precision brain tumor classification with optimized efficientnet architecture
Md Manowarul Islam, Md Alamin Talukder, Md Ashraf Uddin, Arnisha Akhter, and Majdi Khalid. Brainnet: precision brain tumor classification with optimized efficientnet architecture. International Journal of Intelligent Systems, 2024(1):3583612, 2024
2024
-
[11]
An effective and novel approach for brain tumor classification using alexnet cnn feature extractor and multiple eminent machine learning classifiers in mris
Alok Sarkar, Md Maniruzzaman, Mohammad Ashik Alahe, and Mohiuddin Ahmad. An effective and novel approach for brain tumor classification using alexnet cnn feature extractor and multiple eminent machine learning classifiers in mris. Journal of Sensors, 2023(1):1224619, 2023
2023
-
[12]
Vgg-scnet: A vgg net-based deep learning framework for brain tumor detection on mri images
Mohammad Shahjahan Majib, Md Mahbubur Rahman, TM Shahriar Sazzad, Nafiz Imtiaz Khan, and Samrat Kumar Dey. Vgg-scnet: A vgg net-based deep learning framework for brain tumor detection on mri images. IEEE Access, 9:116942–116952, 2021
2021
-
[13]
Brain cancer - mri dataset, 2024
Md Mizanur Rahman. Brain cancer - mri dataset, 2024
2024
-
[14]
François Chollet et al. Keras. https://keras.io, 2015
2015
-
[15]
Martín Abadi, Ashish Agarwal, Paul Barham, Eugene Brevdo, Zhifeng Chen, Craig Citro, Greg S. Corrado, Andy Davis, Jeffrey Dean, Matthieu Devin, Sanjay Ghemawat, Ian Goodfellow, Andrew Harp, Geoffrey Irving, Michael Isard, Yangqing Jia, Rafal Jozefowicz, Lukasz Kaiser, Manjunat...
2015
-
[16]
Grad-cam: visual explanations from deep networks via gradient-based localization
Ramprasaath R Selvaraju, Michael Cogswell, Abhishek Das, Ramakrishna Vedantam, Devi Parikh, and Dhruv Batra. Grad-cam: visual explanations from deep networks via gradient-based localization. International journal of computer vision, 128:336–359, 2020
2020
-
[17]
Explainable convolutional neural networks for retinal fundus classification and cutting-edge segmentation models for retinal blood vessels from fundus images
Fatema Tuj Johora Faria, Mukaffi Bin Moin, Pronay Debnath, Asif Iftekher Fahim, and Faisal Muhammad Shah. Explainable convolutional neural networks for retinal fundus classification and cutting-edge segmentation models for retinal blood vessels from fundus images. arXiv prepri...
2024 arXiv
-
[18]
Grad-cam++: General- ized gradient-based visual explanations for deep convolutional networks
Aditya Chattopadhay, Anirban Sarkar, Prantik Howlader, and Vineeth N Balasubramanian. Grad-cam++: General- ized gradient-based visual explanations for deep convolutional networks. In 2018 IEEE winter conference on applications of computer vision (WACV), pages 839–847. IEEE, 2018. 12
2018
Reviewed August 7, 2026 · model on record in the stance chip above.
Discussion (0). Sign in to comment.